We were lucky to have Linda Kelley, Chief Scientific Officer of Cryo-Cell, present at the World Cord Blood Congress in 2013. You can now download her presentation slides from the event, where she addresses the challenge of transporting fresh cord blood and its impact on quality including viability and potency.
While you’re viewing the slides, you can also view the recording of her presentation. After all, we wouldn’t want you to miss anything, right?
Linda Kelley, Ph.D., is an internationally recognized expert in the cellular therapy field. In her current role as chief scientific officer of Cryo-Cell, Dr. Kelley is responsible for Cryo-Cell’s state-of-the art laboratory, translational medicine initiatives and quality assurance program. She joined Cryo-Cell from the Dana-Farber Cancer Institute at Harvard where she was the director of the Connell O’Reilly Cell Manipulation Core Facility. Prior to that, she spent 17 years at the University of Utah where she was director of the Cell Therapy Facility. She established that state’s first umbilical cord blood collection program and was awarded a Center of Excellence in Cell Therapy and Regenerative Medicine for the State of Utah, which served as a cornerstone for a larger state initiative in Regenerative Medicine — the Utah Science & Technology Research Initiative.
During her presentation, Linda addresses:
- How distinguished is this issue for different bank models – private, public and hybrid
- Looking closer at the types of isolation materials used for transportation
- Designing an off-the-shelf technology/approach that is both cost-effective and high-quality
This year’s event will take place September 15-16 in Boston, MA. Hope to see you there!